Clinical & Translational Research

Dr. Gandra specializes in clinical and public health research with a special focus on antibiotic use, antibiotic resistance surveillance and healthcare epidemiology in resource limited settings especially in India.

Languages: English, Telugu, Hindi

Using the lens of implementation science, Dr. Geng conducts research to advance the use of evidence-based interventions in the public health response to HIV and non-communicable diseases.

Ige George, MD is Director of the WashU Medicine General ID Clinic. As a core faculty member of the ID Fellowship Program, he serves as Director of the Transplant ID Track. Dr. George specializes in clinical research focused on the epidemiology and treatment of infections in the immune compromised hosts and solid organ transplant recipients. He also serves as the TB physician for the St. Louis City TB and Refugee Clinic.

Dr. Grant specializes in the innate immune responses to the pathogens causing Tuberculosis (TB), Nontuberculous Mycobacterial (NTM) and COVID-19 infections, and his laboratory research includes the search for novel therapies targeting the host for these difficult infections.

Dr. Henderson specializes in infection pathogenesis, with a special focus on urinary tract infections and identifying how special bacterial adaptations increase pathogenic potential in patients.

Dr. Hendrix specializes in antimicrobial stewardship and clinical infectious disease with a special focus on COVID-19 and bone marrow transplant (BMT) recipients.

Dr. Hong is a core faculty member of the ID Fellowship Training Program, serving as Co-Director of the STI and HIV Track. He specializes in HIV and STI care, HIV prevention, and public health, with a special focus on outpatient HIV care, HIV PrEP implementation, inpatient outcomes for syphilis treatment, and community education regarding STI diagnosis and treatment.

Dr. Hsueh specializes in Antimicrobial Stewardship and Infection Prevention, with special focus on practical design and implementation of healthcare quality and safety improvement interventions.

Dr. Jenny Hyde leads and performs basic research centered on virus-host interactions. Her work combines molecular virology and RNA biology to uncover the mechanisms by which viral RNA structures regulate RNA-protein interactions, with the goal of identifying new therapeutic targets and advancing antiviral and vaccine development.

A passionate advocate for health equity and sustainability, Dr. Iwelunmor is widely regarded for understanding how to make evidence-based interventions last, reshaping the focus on community engagement using participatory research, improving the dissemination of health information, while amplifying the voices of young people in health interventions.

Dr. Kyei specializes in HIV basic and translational research, with a special focus on viral latency and reactivation specifically:  (i) characterization of factors that control HIV replication in macrophages, dendritic and resting T cells and (ii) identification of cellular factors and small molecules required for HIV reactivation in latently infected cell and (iii) perspectives of HIV patients on HIV cure.

Dr. Liang’s primary research interests include trauma-related infections, orthopedic infections, device-associated infections, and management of infectious diseases and infection prevention in emergency care settings.

Dr. López is a public health researcher who uses her clinical practice skills to further advance the field of sexual health using public health and social work theories and frameworks.

Dr. Marks is a core faculty member of the ID Fellowship Training Program, serving as Director of Fellow Basic/Translational research, infectious diseases and substance use. She specializes in clinical infectious diseases with a special focus on infectious complications in people who inject drugs, such as infective endocarditis and Hepatitis B & C virus infections. Other core research interests include infections in pregnant women.

Dr. Mattar is the section chief for General Infectious Disease and the Associate Program Director of the ID Fellowship Program. As ID Fellowship core faculty, she also serves as Director of Global Health Track. Dr. Mattar's research focuses on infection prevention and antimicrobial stewardship as well as global health with a specific focus on resource-limited settings and health policy.

Dr. McCrary specializes in clinical infectious diseases and addiction medicine with a special focus on the infectious complications of substance use, such as Hepatitis C and Serratia endocarditis, and related quality improvement initiatives.

Eugenia Miranti, MD, MPH is an associate medical director of WashU Infection Prevention and a clinical assistant professor of medicine. As a core faculty member of the Infectious Diseases Fellowship Training Program, she serves as Director of the Hospital Epidemiology Track.

Dr. Mitreva is an internationally acclaimed scientist who leads a basic and translational research program studying neglected tropical diseases, specifically helminth infections. Her enduring dedication to enhancing omics-driven discoveries and their clinical applications is paving the way for long-lasting improvements in global health.